Results
90
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
90 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.48 | 0.1% | -1.2% | SEK 401.9m | SEK 2.20 | PS4.4x | E90.4% | n/a | Tech | ||
CALTX | SEK 206.20 | 0% | 110.9% | SEK 11.1b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
YUBICO | SEK 267.50 | 0.6% | 167.0% | SEK 23.0b | SEK 267.50 | PE139.1x | E43.8% | n/a | Software | ||
MAGLE | SEK 41.00 | -1.0% | 18.5% | SEK 442.8m | SEK 50.00 | PE57.5x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
YIELD | SEK 2.38 | 0.8% | -66.7% | SEK 136.3m | SEK 9.00 | PB1.6x | E103.4% | n/a | Diversified Financials | ||
CTT | SEK 265.00 | -5.7% | 23.3% | SEK 3.3b | n/a | PE32.6x | E24.8% | 2.0% | Capital Goods | ||
EDYOU | SEK 1.30 | 3.7% | 14.4% | SEK 48.6m | n/a | PS1.5x | E63.1% | n/a | Media | ||
BIOA B | SEK 166.50 | -24.9% | -43.8% | SEK 14.7b | SEK 336.40 | PS58.3x | E104.2% | 0% | Pharmaceuticals & Biotech | ||
BIOVIC B | SEK 2.96 | 3.1% | -70.5% | SEK 248.8m | SEK 7.90 | PS34.1x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.37 | 2.6% | -19.9% | SEK 256.3m | SEK 3.65 | PS2.7x | E104.9% | n/a | Tech | ||
CRAD B | SEK 43.50 | -4.4% | 55.9% | SEK 1.5b | SEK 57.00 | PE27.4x | E33.9% | n/a | Healthcare | ||
ORGC | SEK 3.35 | -2.9% | -21.5% | SEK 328.7m | SEK 3.00 | PS2.4x | E109.0% | n/a | Materials | ||
ORT B | SEK 10.35 | 13.5% | 34.8% | SEK 383.8m | SEK 19.50 | PS6.2x | E91.6% | n/a | Healthcare | ||
CTM | SEK 6.44 | -12.1% | -73.3% | SEK 487.2m | SEK 29.70 | PB0.2x | E115.4% | 0% | Media | ||
FLEXQ | SEK 11.00 | 3.3% | -59.4% | SEK 147.4m | SEK 25.00 | PS1.2x | E111.9% | n/a | Capital Goods | ||
MIDS | SEK 1.33 | -0.9% | -42.6% | SEK 279.8m | SEK 2.80 | PS4.3x | E89.9% | n/a | Semiconductors | ||
TRUE B | SEK 33.10 | -1.2% | -17.3% | SEK 11.4b | SEK 54.83 | PE24x | E21.5% | 1.2% | Software | ||
EQT | SEK 339.40 | 2.6% | 43.2% | SEK 401.5b | SEK 366.15 | PE115.1x | E56.7% | 1.0% | Diversified Financials | ||
KLAR | SEK 0.31 | -17.4% | -49.5% | SEK 40.1m | SEK 1.00 | PB1.4x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
SENZA | SEK 6.95 | -2.8% | -35.3% | SEK 205.1m | SEK 16.50 | PS3.9x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
4C | SEK 19.95 | 5.3% | -23.3% | SEK 700.9m | SEK 22.00 | PS2.4x | E108.0% | n/a | Software | ||
NIUTEC | SEK 6.40 | -3.9% | -44.2% | SEK 129.1m | SEK 9.50 | PB1.5x | E94.1% | n/a | Capital Goods | ||
EGTX | SEK 5.87 | -5.0% | 38.3% | SEK 1.7b | SEK 13.30 | PS27.3x | E98.6% | n/a | Pharmaceuticals & Biotech | ||
FNOX | SEK 65.02 | 0.3% | 5.0% | SEK 39.7b | SEK 73.00 | PE61x | E22.6% | 0.3% | Software |